BIO (BIO) Stock Price & Analysis
BIO (BIO) rose 0.00% to USD 314.46 as of July 25, 2026 at 02:22 UTC, according to Nexqual real-time market data.
BIO last closed at USD 314.46; the session ranged USD 311.66–316.93 on volume of 247,010 shares. Market capitalization is —, with a 52-week range of USD 236.73–343.12 (NYQ). Source: Nexqual, July 25, 2026 at 02:22 UTC.
Key Statistics (as of July 25, 2026 at 02:22 UTC)
| Price | USD 314.46 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 314.46 |
| Open | USD 314.46 |
| Day Range | USD 311.66 – 316.93 |
| 52-Week Range | USD 236.73 – 343.12 |
| Volume | 247,010 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (BIO)
Nexqual's technical model rates BIO "BUY" based on 5 bullish and 2 bearish signals across 125 daily candles, as of July 25, 2026 at 02:22 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 63.18 (neutral) |
| vs SMA50 | Above (USD 292.67) |
| MACD | 5.41 (positive) |
From BIO's Latest SEC 10-K Filing (filed 2026-02-13)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MTD | Mettler-Toledo International, I | USD 1,327.18 | ▲ 3.21% |
| CRL | Charles River Laboratories Inte | USD 226.58 | ▲ 3.6% |
| WST | West Pharmaceutical Services, I | USD 328.2 | ▼ 8.43% |
| TFX | Teleflex Incorporated | USD 132.1 | ▼ 2% |
| COO | The Cooper Companies, Inc. | USD 70.31 | ▼ 0.27% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 02:22 UTC. This page is informational and not investment advice.